ArticleBMC infectious diseases2025
Differences in the clinical course of COVID-19 in children and adolescents hospitalized in the 2023/2024 and 2024/2025 seasons - a retrospective real-world study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis multicenter retrospective study was designed to track changes in the clinical presentation of COVID-19 in children that occurred in the last two infectious seasons, and to identify risk factors for severe disease progression.
methodsThe analysis covered all consecutive children hospitalized due to COVID-19 during the 2023/2024 and 2024/2025 infectious seasons in Polish pediatric centers.
resultsOf the 366 children included in the study, 203 were hospitalized in the first period analyzed and 163 in the second. In both seasons, about three-quarters of the population were children under 2 years of age, boys were hospitalized more often than girls and more than a one-fourth had comorbidities. Oxygen saturation (SpO2) upon admission was significantly lower in the 2023/2024 season. Children in unstable clinical condition with SpO2 ≤ 95% were admitted to hospital statistically more often in the first period analyzed. Eleven patients were admitted in unstable clinical condition with SpO2 < 90%, nine of whom were hospitalized during the period 2023/2024. Nine of them were aged one year or younger, and seven had comorbidities. Oxygen supplementation was used significantly more often in the first period analyzed, high-flow therapy was used in three children hospitalized in the 2023/2024 season, while one child required mechanical ventilation in the 2024/2025 season.
conclusionsWith each season of Omicron dominance, the course of COVID-19 in pediatric patients is becoming milder. Special attention should be paid to the youngest children and those with comorbidities, as the disease may progress more rapidly and lead to severe course in this population. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.